[2]
Unnisa, A.; Parven, T.D. Anti-inflammatory and acute toxicity studies of the extracts from the rhizomes of Alpinia galangal Willd. Pharm. Sin., 2011, 2(2), 361-367.
[3]
Kaliyadasa, E.; Samarasinghe, B.A. Genus alpinia, a potential powerhouse of bioactive: A review. Int. J. Pharm. Sci. Res., 2019, 10(6), 2644-2653.
[4]
Verma, R.K.; Garima, M.; Pradeep, S.; Jha, K.K.; Khosa, R.L. Alpinia galanga-an important medicinal plant: A review. Pharm. Sin., 2011, 2(1), 142-154.
[5]
Vanwyk, B.E.; Wink, M. Medicinal plant of the world, 1st ed; Briz Publication: South Africa, 2009.
[6]
Patel, B.V. A Report of The Seminar on, Herbal Drugs: Present Status and Future Prospects; Perd Centre: Ahmedabad, 2001.
[7]
Ghosh, S.; Rangan, L. Alpinia: The gold mine of future therapeutics. 3 Biotech, 2013, 3(3), 173-185.
[8]
Paul, T.; Devasagayam, A. Radiation Biology and Health Sciences Division; Bhabha Atomic Research Centre: Mumbai, 2006.
[9]
Jain, J.B.; Kumane, S.C.; Bhattacharya, S. Medicinal flora of Madhya Pradesh and Chattisgarh-a review. Indian J. Tradit. Knowl., 2006, 5(2), 237-242.
[10]
World Health Organization Research guidelines for evaluating the safety and efficacy of herbal medicines; WHO Regional Office for the Western Pacific: Manila, 1993.
[13]
Victório, C.P.; Lage, C.L.S. Uso de plantas medicinais. Revista Arquivos FOG-Saúde, Sociedade. Gestão e Meio Ambiente, 2008, 5(1), 33-41.
[22]
Tomlinson, P.B. Anatomy of the monocotyledons. III, Commelinales-zingiberales. Oxford: Clarendon press; , 1969.
[25]
Sirirugsa, P. Thai Zingiberaceae: Species diversity and their uses. Pure Appl. Chem., 1999, 70, 1-8.
[27]
Thirumurugan, D.; Cholarajan, A.; Raja, S.S.; Vijayakumar, R. An Introductory Chapter: Secondary Metabolites In: Secondary Metabolites: Sources and Applications, Vijayakumar R.; Suresh S.S. Raja, Ed(s). , 2018; 148, .
[40]
Da Costa, L.A.M.A.; Morais, S.M.; Dantas, M.C.B.R.; Lobo, R.A.C.M.; Fonteles, M.C. Flavonóides com atividade hipotensora de Alpinia zerumbet (Pers.) Burt et Smith (colônia). Rev. Bras. Farmacogn., 1998, 79, 96-98.
[51]
Matsuda, H.; Morikawa, T.; Managi, H.; Yoshikawa, M. Antiallergic principles from Alpinia galanga: Structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-α and IL-4 in RBL-2H3 cells. Bioorg. Med. Chem. Lett., 2003, 13(19), 3197-3202.
[55]
Satish, R.; Dhananjayan, R. Evaluation of anti-inflammatory potential of rhizome of Alpinia galanga Linn. Biomedicine-Trivandrum Then Taramani, 2003, 23(1/2), 91-96.
[74]
Grienke, U.; Schmidtke, M.; Kirchmair, J.; Pfarr, K.; Wutzler, P.; Dürrwald, R.; Wolber, G.; Liedl, K.R.; Stuppner, H.; Rollinger, J.M. Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J. Med. Chem., 2009, 53(2), 778-786.
[75]
Nam, J.W.; Kim, S.J.; Han, A.R.; Lee, S.K.; Seo, E.K. Cytotoxic phenylpropanoids from the rhizomes of Alpinia galanga. Biomolec. Therapeut., 2005, 13(4), 263-266.
[84]
Basri, A.M.; Taha, H.; Ahmad, N. A review on the pharmacological activities and phytochemicals of Alpinia officinarum (Galangal) extracts derived from bioassay-guided fractionation and isolation. Pharmacogn. Rev., 2017, 11(21), 23.